ARAY: שווי חברה לרווח נקי Accuray Inc

This chart of Accuray Incorporated (ARAY) share prices on the GURU.Markets platform, where the P/E ratio stands at -0.70, illustrates the company's strategy for the global expansion of CyberKnife systems across clinics. The business generates revenue through multi-year maintenance of high-cost therapy robots and staff training. The stability of the R&D center is maintained by retaining leading biomedical engineers and attracting specialized trainers.

The P/E ratio reflects the relationship between the market value of Accuray Incorporated (ARAY) and its net income, revealing the actual efficiency of its capitalization. By analyzing changes in the company's P/E, an investor can determine the extent to which market expectations align with the business's ability to generate income. For a manufacturer of radiation therapy systems, this indicator is critical, as the high margins of service contracts must offset the high cost of robot assembly. The multiplier's dynamics make it possible to distinguish an undervalued asset from a pre-bankruptcy state.